The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Early-onset colorectal cancer is behaving like a new, biologically distinct disease, researchers note
One woman’s pregnancy shows how this distinction matters

Cancer Policy

AACR urges OMB to retract proposed rule on federally funded research

CDC updates ACIP charter

Visa delays continue as residency programs begin

FDA allows ZYN nicotine pouches to make marketing claim: ZYN is safer than cigarettes

Student loan caps go into effect for medical students

FDA advisory panel recommends first-of-its-kind mRNA flu vaccine for older adults

Clinical Roundup

MammaPrint + BluePrint genomic profiling predicts anthracycline chemotherapy benefit in HR+HER2- early-stage breast cancer

Despite overall decline in secondary cancer diagnoses, female lung cancer survivors saw 60% increase from the 1970s to the 2010s, VCU Massey analysis finds

UTSW study shows how RNA-modifying enzyme linked to cancer picks its targets

Thymus may help prepare CD8+ T cells for rapid response before circulation, Mayo study suggests

NYU Langone study sheds light on early respiratory failure in AML

Alliance launches study of immunotherapy to prevent lung cancer recurrence

In The Clinic
Trials & Tribulations

What NHS-Galleri taught us—and what it didn’t

Trials & Tribulations
FreeTrials & Tribulations
Trials & Tribulations

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account